Valuation: Cencora, Inc.

Market Cap 58.57B 51.51B 48.71B 44.18B 82.97B 5,622B 83.45B 583B 225B 2,869B 220B 215B 9,219B P/E 2026 *
16.8x
P/E 2027 * 18.3x
Enterprise Value 66.26B 58.27B 55.11B 49.98B 93.87B 6,360B 94.41B 660B 255B 3,246B 249B 243B 10,429B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.77%
Yield 2027 * 0.79%
1 day-1.69%
1 week-0.04%
Current month-2.98%
1 month-4.20%
3 months+6.93%
6 months-2.32%
Current year-15.17%
1 week 266.8
Extreme 266.8
273.1
1 month 266.5
Extreme 266.5
287.1
Current year 212.9
Extreme 212.9
316.5
1 year 212.9
Extreme 212.9
327.1
3 years 171.2
Extreme 171.2
327.1
5 years 101
Extreme 101
327.1
10 years 58.64
Extreme 58.644
327.1
Manager TitleAgeSince
Chief Executive Officer 59 30/09/2024
Director of Finance/CFO 59 28/06/2026
Chief Tech/Sci/R&D Officer 50 03/11/2024
Director TitleAgeSince
Director/Board Member 75 15/05/2013
Director/Board Member 59 30/09/2024
Chairman 64 30/09/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-0.04% - - 58.57B
-0.31%-1.94%-24.14%+2.91% 175B
+0.97%-2.45%-4.76%+13.74% 113B
-1.01%-4.01%-1.38%+66.14% 58.57B
+0.01%+1.73%-0.09%-30.03% 50.07B
+0.45%+4.36%+15.64%+53.13% 49.92B
+0.07%-2.79%+30.42%-9.20% 32.69B
+1.07%+9.73% - - 30.44B
+1.41%+3.83%+44.30%-0.90% 26.07B
+1.98%+9.34%+26.26%-2.43% 23.55B
Average +0.29%+1.76%+10.78%+11.67% 62.22B
Weighted average by Cap. +0.08%+0.01%-2.47%+12.67%

Financials

2026 *2027 *
Net sales 337B 296B 280B 254B 477B 32,350B 480B 3,356B 1,296B 16,508B 1,265B 1,238B 53,047B 353B 310B 294B 266B 500B 33,882B 503B 3,515B 1,357B 17,289B 1,325B 1,296B 55,559B
Net income 3.58B 3.15B 2.98B 2.7B 5.07B 344B 5.1B 35.65B 13.77B 175B 13.44B 13.15B 564B 2.84B 2.5B 2.37B 2.15B 4.03B 273B 4.05B 28.33B 10.94B 139B 10.68B 10.45B 448B
Net Debt 7.69B 6.76B 6.4B 5.8B 10.89B 738B 10.96B 76.58B 29.58B 377B 28.87B 28.25B 1,211B 9.44B 8.3B 7.85B 7.12B 13.37B 906B 13.45B 93.97B 36.29B 462B 35.43B 34.66B 1,485B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
28/09/26 €266.80 -1.84%
25/09/26 €271.80 +0.07%
24/09/26 €271.60 -0.29%
23/09/26 €272.40 -0.26%
22/09/26 €273.10 +2.48%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
306.92USD
Average target price
369.25USD
Spread / Average Target
+20.31%

Quarterly revenue - Rate of surprise